🇺🇸·1d agoResearch
NCT07713459: A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas
Study type: INTERVENTIONAL. Phase: PHASE2.
Publisher
C
ClinicalTrials.gov
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- ClinicalTrials.gov
- Region
- USA
- Scope
- Research
- Published
- July 20, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Study type: INTERVENTIONAL. Phase: PHASE2.
Source route
Continue on clinicaltrials.gov
Leave the platform to read the original full article on the publisher site.
Source: ClinicalTrials.gov
Scope: Research
Related coverage
More related coverage
CU Anschutz Medical/14h ago
Peptides Explained: What They Do, How They Work and What to Know About Peptide Therapy
Cancer Research UK/15h ago
Data science: making data count with broad consent
UNC Chapel Hill/15h ago
Carolina North will complement University’s vibrant campus
Université de Paris/17h ago